Cambridge Investment Research Advisors
BMRA icon

Cambridge Investment Research Advisors’s Biomerica BMRA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,266
Closed -$3K – 3517
2024
Q4 		$3K Buy
+1,266
New +$3.34K ﹤0.01% 3457

Other funds holding BMRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BWM
Bulltick Wealth Management Miami, Florida $490M AUM 12.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors's BMRA Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Biomerica (BMRA) in Q1 2025, closing a stake of 1,266 shares — an estimated $3K sold.

Cambridge Investment Research Advisors first reported a position in BMRA in Q4 2024 and held it in 1 quarter. The position peaked at $3K in Q4 2024. 24 funds tracked by Wall St. Rank hold BMRA as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Biomerica position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,266 Biomerica shares in Q1 2025, an estimated $3K.
  • Cambridge Investment Research Advisors first reported a position in Biomerica in Q4 2024 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Biomerica position peaked at $3K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Biomerica as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.